AME's Spinal-Stim
This article was originally published in The Gray Sheet
Executive Summary
American Medical Electronics gains FDA approval of a premarket approval supplement to reduce Spinal-Stim treatment time from eight to two hours. AME says that it has just begun a "guarantee" program for patients using the bone stimulator as an adjunct to lumbar fusion surgery; patients who comply with use guidelines but are diagnosed as having a radiographic fusion failure will be fully reimbursed for Spinal-Stim rental fees. "The combination of the significantly lower daily treatment time and money-back guarantee provides a much stronger argument for surgeons to prescribe Spinal-Stim units to help increase the potential heal rate for their patients," the company says.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.